{
  "docId": "019de076-9b15-737c-b05c-8347f7a98ad7",
  "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6",
  "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 28,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "solution",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 8,
  "notes": "The slide presents two bar charts comparing control, tumor, tumor+mock, and tumor+TD groups under different treatment conditions (IL2 vs aCD16).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/19",
  "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7",
  "deckJsonHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7.json",
  "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "IL2 treatment per group",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7018dac8-1b4d-4381-b287-9ece7c191cad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "chart",
      "text": "aCD16 per group",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85abf1cc-7835-42f7-ba31-d7b97aea501b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.58,
        "y": 0.87
      },
      "kind": "paragraph",
      "text": "*anti-CD16 specifically blocks induced NK-mediated Killing to show response specificity",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cdb04e3a-fbc0-4b43-a835-e96f0a6db95c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "RENB-DC11 ACTIVATES NATURAL KILLER CELL-MEDIATED KILLING OF PANCREATIC TUMOR CELLS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55d32905-6e55-4ee1-a7a5-89ad6914961b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "306ffd69-3ca7-4416-97e1-22a5c2275153",
      "evidence": "chart/bar-vertical: IL2 treatment per group, chart/bar-vertical: aCD16 per group",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 5,
      "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    },
    {
      "to": 23,
      "from": 6,
      "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.",
      "position": 3,
      "confidence": 0.9,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}